Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5200861
Max Phase: Preclinical
Molecular Formula: C52H63Cl2N7O9S
Molecular Weight: 1033.09
Associated Items:
ID: ALA5200861
Max Phase: Preclinical
Molecular Formula: C52H63Cl2N7O9S
Molecular Weight: 1033.09
Associated Items:
Canonical SMILES: Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCOCCOCCOCCOc2ccc(-c3cn4c(n3)CCC4)cc2CNC(=O)Cc2ccc(Cl)c(Cl)c2)C(C)(C)C)cc1
Standard InChI: InChI=1S/C52H63Cl2N7O9S/c1-33-48(71-32-57-33)36-10-7-34(8-11-36)28-56-50(65)43-27-39(62)30-61(43)51(66)49(52(2,3)4)59-46(63)15-17-67-18-19-68-20-21-69-22-23-70-44-14-12-37(42-31-60-16-5-6-45(60)58-42)26-38(44)29-55-47(64)25-35-9-13-40(53)41(54)24-35/h7-14,24,26,31-32,39,43,49,62H,5-6,15-23,25,27-30H2,1-4H3,(H,55,64)(H,56,65)(H,59,63)/t39-,43+,49-/m1/s1
Standard InChI Key: LDNZZSMPSRDFMJ-SHTJZPIOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1033.09 | Molecular Weight (Monoisotopic): 1031.3785 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Dölle A, Adhikari B, Krämer A, Weckesser J, Berner N, Berger LM, Diebold M, Szewczyk MM, Barsyte-Lovejoy D, Arrowsmith CH, Gebel J, Löhr F, Dötsch V, Eilers M, Heinzlmeir S, Kuster B, Sotriffer C, Wolf E, Knapp S.. (2021) Design, Synthesis, and Evaluation of WD-Repeat-Containing Protein 5 (WDR5) Degraders., 64 (15.0): [PMID:33980013] [10.1021/acs.jmedchem.1c00146] |
Source(1):